stf 62247 (MedChemExpress)
Structured Review
Stf 62247, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stf/STF-62247/pmc13006433-367-69-75
Average 94 stars, based on 2 article reviews
Images
Related Articles
Drug discovery:Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer Article Snippet: The percentage of PI-positive cells was quantified.The percentage of PI-positive cells was quantified.. To validate cell death inhibitors, RCC10 (1 × 10 5 cells/well) cells were seeded onto the 12-well plate for 12 h and pre-treated for 30 min with vehicle, Necrostatin-1 (10 μM), Ferrostatin-1 (2 μM), 3-MA (1.25 mM), or AC-FLTD-CMK (10 μM), followed by 3 days of co-treatment with vehicle or respective cell death activator, including Compound6i (0.5 μM, necroptosis activator, HY-144828, MCE), RSL3 (50 nM, ferroptosis activator, HY-100218A, MCE), Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer. Article Snippet: ssue Kit Qiagen Cat# 69504 RNeasy mini kit Qiagen Cat# 74104 KAPA mRNA HyperPrep Kit Roche Cat# 08098123702 Bioactive Compound Library Selleckchem Cat# L1700 Chemicals and recombinant proteins SGI1027 Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer. Article Snippet: The percentage of PI-positive cells was quantified.The percentage of PI-positive cells was quantified.. To validate cell death inhibitors, RCC10 (1 × 10 5 cells/well) cells were seeded onto the 12-well plate for 12 h and pre-treated for 30 min with vehicle, Necrostatin-1 (10 μM), Ferrostatin-1 (2 μM), 3-MA (1.25 mM), or AC-FLTD-CMK (10 μM), followed by 3 days of cotreatment with vehicle or respective cell death activator, including Compound6i (0.5 μM, necroptosis activator, HY-144828, MCE), RSL3 (50 nM, ferroptosis activator, HY-100218A, MCE), Article Title: Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA. Article Snippet: Zn (NO3)2•6H2O and 2-MeIM were purchased from Aladdin Holdings Group Co., Ltd (Shanghai); PEGFA 2000, ICG, and FITC from Rixi Biotechnology Co., Ltd. (Xi’an); BMS202 (HY-19745), Article Title: Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA Article Snippet: Zn (NO3)2•6H2O and 2-MeIM were purchased from Aladdin Holdings Group Co., Ltd (Shanghai); PEG-FA 2000, ICG, and FITC from Rixi Biotechnology Co., Ltd. (Xi’an); BMS202 (HY-19745), Recombinant:Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer Article Snippet: The percentage of PI-positive cells was quantified.The percentage of PI-positive cells was quantified.. To validate cell death inhibitors, RCC10 (1 × 10 5 cells/well) cells were seeded onto the 12-well plate for 12 h and pre-treated for 30 min with vehicle, Necrostatin-1 (10 μM), Ferrostatin-1 (2 μM), 3-MA (1.25 mM), or AC-FLTD-CMK (10 μM), followed by 3 days of co-treatment with vehicle or respective cell death activator, including Compound6i (0.5 μM, necroptosis activator, HY-144828, MCE), RSL3 (50 nM, ferroptosis activator, HY-100218A, MCE), Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer. Article Snippet: ssue Kit Qiagen Cat# 69504 RNeasy mini kit Qiagen Cat# 74104 KAPA mRNA HyperPrep Kit Roche Cat# 08098123702 Bioactive Compound Library Selleckchem Cat# L1700 Chemicals and recombinant proteins SGI1027 Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer. Article Snippet: The percentage of PI-positive cells was quantified.The percentage of PI-positive cells was quantified.. To validate cell death inhibitors, RCC10 (1 × 10 5 cells/well) cells were seeded onto the 12-well plate for 12 h and pre-treated for 30 min with vehicle, Necrostatin-1 (10 μM), Ferrostatin-1 (2 μM), 3-MA (1.25 mM), or AC-FLTD-CMK (10 μM), followed by 3 days of cotreatment with vehicle or respective cell death activator, including Compound6i (0.5 μM, necroptosis activator, HY-144828, MCE), RSL3 (50 nM, ferroptosis activator, HY-100218A, MCE), Article Title: Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA. Article Snippet: Zn (NO3)2•6H2O and 2-MeIM were purchased from Aladdin Holdings Group Co., Ltd (Shanghai); PEGFA 2000, ICG, and FITC from Rixi Biotechnology Co., Ltd. (Xi’an); BMS202 (HY-19745), Article Title: Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA Article Snippet: Zn (NO3)2•6H2O and 2-MeIM were purchased from Aladdin Holdings Group Co., Ltd (Shanghai); PEG-FA 2000, ICG, and FITC from Rixi Biotechnology Co., Ltd. (Xi’an); BMS202 (HY-19745), Spectroscopy:Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer Article Snippet: The percentage of PI-positive cells was quantified.The percentage of PI-positive cells was quantified.. To validate cell death inhibitors, RCC10 (1 × 10 5 cells/well) cells were seeded onto the 12-well plate for 12 h and pre-treated for 30 min with vehicle, Necrostatin-1 (10 μM), Ferrostatin-1 (2 μM), 3-MA (1.25 mM), or AC-FLTD-CMK (10 μM), followed by 3 days of co-treatment with vehicle or respective cell death activator, including Compound6i (0.5 μM, necroptosis activator, HY-144828, MCE), RSL3 (50 nM, ferroptosis activator, HY-100218A, MCE), Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer. Article Snippet: ssue Kit Qiagen Cat# 69504 RNeasy mini kit Qiagen Cat# 74104 KAPA mRNA HyperPrep Kit Roche Cat# 08098123702 Bioactive Compound Library Selleckchem Cat# L1700 Chemicals and recombinant proteins SGI1027 Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer. Article Snippet: The percentage of PI-positive cells was quantified.The percentage of PI-positive cells was quantified.. To validate cell death inhibitors, RCC10 (1 × 10 5 cells/well) cells were seeded onto the 12-well plate for 12 h and pre-treated for 30 min with vehicle, Necrostatin-1 (10 μM), Ferrostatin-1 (2 μM), 3-MA (1.25 mM), or AC-FLTD-CMK (10 μM), followed by 3 days of cotreatment with vehicle or respective cell death activator, including Compound6i (0.5 μM, necroptosis activator, HY-144828, MCE), RSL3 (50 nM, ferroptosis activator, HY-100218A, MCE), Article Title: Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA. Article Snippet: Zn (NO3)2•6H2O and 2-MeIM were purchased from Aladdin Holdings Group Co., Ltd (Shanghai); PEGFA 2000, ICG, and FITC from Rixi Biotechnology Co., Ltd. (Xi’an); BMS202 (HY-19745), Article Title: Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA Article Snippet: Zn (NO3)2•6H2O and 2-MeIM were purchased from Aladdin Holdings Group Co., Ltd (Shanghai); PEG-FA 2000, ICG, and FITC from Rixi Biotechnology Co., Ltd. (Xi’an); BMS202 (HY-19745), Transmission Assay:Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer Article Snippet: The percentage of PI-positive cells was quantified.The percentage of PI-positive cells was quantified.. To validate cell death inhibitors, RCC10 (1 × 10 5 cells/well) cells were seeded onto the 12-well plate for 12 h and pre-treated for 30 min with vehicle, Necrostatin-1 (10 μM), Ferrostatin-1 (2 μM), 3-MA (1.25 mM), or AC-FLTD-CMK (10 μM), followed by 3 days of co-treatment with vehicle or respective cell death activator, including Compound6i (0.5 μM, necroptosis activator, HY-144828, MCE), RSL3 (50 nM, ferroptosis activator, HY-100218A, MCE), Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer. Article Snippet: ssue Kit Qiagen Cat# 69504 RNeasy mini kit Qiagen Cat# 74104 KAPA mRNA HyperPrep Kit Roche Cat# 08098123702 Bioactive Compound Library Selleckchem Cat# L1700 Chemicals and recombinant proteins SGI1027 Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer. Article Snippet: The percentage of PI-positive cells was quantified.The percentage of PI-positive cells was quantified.. To validate cell death inhibitors, RCC10 (1 × 10 5 cells/well) cells were seeded onto the 12-well plate for 12 h and pre-treated for 30 min with vehicle, Necrostatin-1 (10 μM), Ferrostatin-1 (2 μM), 3-MA (1.25 mM), or AC-FLTD-CMK (10 μM), followed by 3 days of cotreatment with vehicle or respective cell death activator, including Compound6i (0.5 μM, necroptosis activator, HY-144828, MCE), RSL3 (50 nM, ferroptosis activator, HY-100218A, MCE), Article Title: Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA. Article Snippet: Zn (NO3)2•6H2O and 2-MeIM were purchased from Aladdin Holdings Group Co., Ltd (Shanghai); PEGFA 2000, ICG, and FITC from Rixi Biotechnology Co., Ltd. (Xi’an); BMS202 (HY-19745), Article Title: Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA Article Snippet: Zn (NO3)2•6H2O and 2-MeIM were purchased from Aladdin Holdings Group Co., Ltd (Shanghai); PEG-FA 2000, ICG, and FITC from Rixi Biotechnology Co., Ltd. (Xi’an); BMS202 (HY-19745), Western Blot:Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer Article Snippet: The percentage of PI-positive cells was quantified.The percentage of PI-positive cells was quantified.. To validate cell death inhibitors, RCC10 (1 × 10 5 cells/well) cells were seeded onto the 12-well plate for 12 h and pre-treated for 30 min with vehicle, Necrostatin-1 (10 μM), Ferrostatin-1 (2 μM), 3-MA (1.25 mM), or AC-FLTD-CMK (10 μM), followed by 3 days of co-treatment with vehicle or respective cell death activator, including Compound6i (0.5 μM, necroptosis activator, HY-144828, MCE), RSL3 (50 nM, ferroptosis activator, HY-100218A, MCE), Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer. Article Snippet: ssue Kit Qiagen Cat# 69504 RNeasy mini kit Qiagen Cat# 74104 KAPA mRNA HyperPrep Kit Roche Cat# 08098123702 Bioactive Compound Library Selleckchem Cat# L1700 Chemicals and recombinant proteins SGI1027 Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer. Article Snippet: The percentage of PI-positive cells was quantified.The percentage of PI-positive cells was quantified.. To validate cell death inhibitors, RCC10 (1 × 10 5 cells/well) cells were seeded onto the 12-well plate for 12 h and pre-treated for 30 min with vehicle, Necrostatin-1 (10 μM), Ferrostatin-1 (2 μM), 3-MA (1.25 mM), or AC-FLTD-CMK (10 μM), followed by 3 days of cotreatment with vehicle or respective cell death activator, including Compound6i (0.5 μM, necroptosis activator, HY-144828, MCE), RSL3 (50 nM, ferroptosis activator, HY-100218A, MCE), Article Title: Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA. Article Snippet: Zn (NO3)2•6H2O and 2-MeIM were purchased from Aladdin Holdings Group Co., Ltd (Shanghai); PEGFA 2000, ICG, and FITC from Rixi Biotechnology Co., Ltd. (Xi’an); BMS202 (HY-19745), Article Title: Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA Article Snippet: Zn (NO3)2•6H2O and 2-MeIM were purchased from Aladdin Holdings Group Co., Ltd (Shanghai); PEG-FA 2000, ICG, and FITC from Rixi Biotechnology Co., Ltd. (Xi’an); BMS202 (HY-19745), Transfection:Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer Article Snippet: The percentage of PI-positive cells was quantified.The percentage of PI-positive cells was quantified.. To validate cell death inhibitors, RCC10 (1 × 10 5 cells/well) cells were seeded onto the 12-well plate for 12 h and pre-treated for 30 min with vehicle, Necrostatin-1 (10 μM), Ferrostatin-1 (2 μM), 3-MA (1.25 mM), or AC-FLTD-CMK (10 μM), followed by 3 days of co-treatment with vehicle or respective cell death activator, including Compound6i (0.5 μM, necroptosis activator, HY-144828, MCE), RSL3 (50 nM, ferroptosis activator, HY-100218A, MCE), Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer. Article Snippet: ssue Kit Qiagen Cat# 69504 RNeasy mini kit Qiagen Cat# 74104 KAPA mRNA HyperPrep Kit Roche Cat# 08098123702 Bioactive Compound Library Selleckchem Cat# L1700 Chemicals and recombinant proteins SGI1027 Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer. Article Snippet: The percentage of PI-positive cells was quantified.The percentage of PI-positive cells was quantified.. To validate cell death inhibitors, RCC10 (1 × 10 5 cells/well) cells were seeded onto the 12-well plate for 12 h and pre-treated for 30 min with vehicle, Necrostatin-1 (10 μM), Ferrostatin-1 (2 μM), 3-MA (1.25 mM), or AC-FLTD-CMK (10 μM), followed by 3 days of cotreatment with vehicle or respective cell death activator, including Compound6i (0.5 μM, necroptosis activator, HY-144828, MCE), RSL3 (50 nM, ferroptosis activator, HY-100218A, MCE), Article Title: Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA. Article Snippet: Zn (NO3)2•6H2O and 2-MeIM were purchased from Aladdin Holdings Group Co., Ltd (Shanghai); PEGFA 2000, ICG, and FITC from Rixi Biotechnology Co., Ltd. (Xi’an); BMS202 (HY-19745), Article Title: Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA Article Snippet: Zn (NO3)2•6H2O and 2-MeIM were purchased from Aladdin Holdings Group Co., Ltd (Shanghai); PEG-FA 2000, ICG, and FITC from Rixi Biotechnology Co., Ltd. (Xi’an); BMS202 (HY-19745), Plasmid Preparation:Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer Article Snippet: The percentage of PI-positive cells was quantified.The percentage of PI-positive cells was quantified.. To validate cell death inhibitors, RCC10 (1 × 10 5 cells/well) cells were seeded onto the 12-well plate for 12 h and pre-treated for 30 min with vehicle, Necrostatin-1 (10 μM), Ferrostatin-1 (2 μM), 3-MA (1.25 mM), or AC-FLTD-CMK (10 μM), followed by 3 days of co-treatment with vehicle or respective cell death activator, including Compound6i (0.5 μM, necroptosis activator, HY-144828, MCE), RSL3 (50 nM, ferroptosis activator, HY-100218A, MCE), Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer. Article Snippet: ssue Kit Qiagen Cat# 69504 RNeasy mini kit Qiagen Cat# 74104 KAPA mRNA HyperPrep Kit Roche Cat# 08098123702 Bioactive Compound Library Selleckchem Cat# L1700 Chemicals and recombinant proteins SGI1027 Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer. Article Snippet: The percentage of PI-positive cells was quantified.The percentage of PI-positive cells was quantified.. To validate cell death inhibitors, RCC10 (1 × 10 5 cells/well) cells were seeded onto the 12-well plate for 12 h and pre-treated for 30 min with vehicle, Necrostatin-1 (10 μM), Ferrostatin-1 (2 μM), 3-MA (1.25 mM), or AC-FLTD-CMK (10 μM), followed by 3 days of cotreatment with vehicle or respective cell death activator, including Compound6i (0.5 μM, necroptosis activator, HY-144828, MCE), RSL3 (50 nM, ferroptosis activator, HY-100218A, MCE), Article Title: Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA. Article Snippet: Zn (NO3)2•6H2O and 2-MeIM were purchased from Aladdin Holdings Group Co., Ltd (Shanghai); PEGFA 2000, ICG, and FITC from Rixi Biotechnology Co., Ltd. (Xi’an); BMS202 (HY-19745), Article Title: Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA Article Snippet: Zn (NO3)2•6H2O and 2-MeIM were purchased from Aladdin Holdings Group Co., Ltd (Shanghai); PEG-FA 2000, ICG, and FITC from Rixi Biotechnology Co., Ltd. (Xi’an); BMS202 (HY-19745), Microscopy:Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer Article Snippet: The percentage of PI-positive cells was quantified.The percentage of PI-positive cells was quantified.. To validate cell death inhibitors, RCC10 (1 × 10 5 cells/well) cells were seeded onto the 12-well plate for 12 h and pre-treated for 30 min with vehicle, Necrostatin-1 (10 μM), Ferrostatin-1 (2 μM), 3-MA (1.25 mM), or AC-FLTD-CMK (10 μM), followed by 3 days of co-treatment with vehicle or respective cell death activator, including Compound6i (0.5 μM, necroptosis activator, HY-144828, MCE), RSL3 (50 nM, ferroptosis activator, HY-100218A, MCE), Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer. Article Snippet: ssue Kit Qiagen Cat# 69504 RNeasy mini kit Qiagen Cat# 74104 KAPA mRNA HyperPrep Kit Roche Cat# 08098123702 Bioactive Compound Library Selleckchem Cat# L1700 Chemicals and recombinant proteins SGI1027 Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer. Article Snippet: The percentage of PI-positive cells was quantified.The percentage of PI-positive cells was quantified.. To validate cell death inhibitors, RCC10 (1 × 10 5 cells/well) cells were seeded onto the 12-well plate for 12 h and pre-treated for 30 min with vehicle, Necrostatin-1 (10 μM), Ferrostatin-1 (2 μM), 3-MA (1.25 mM), or AC-FLTD-CMK (10 μM), followed by 3 days of cotreatment with vehicle or respective cell death activator, including Compound6i (0.5 μM, necroptosis activator, HY-144828, MCE), RSL3 (50 nM, ferroptosis activator, HY-100218A, MCE), Article Title: Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA. Article Snippet: Zn (NO3)2•6H2O and 2-MeIM were purchased from Aladdin Holdings Group Co., Ltd (Shanghai); PEGFA 2000, ICG, and FITC from Rixi Biotechnology Co., Ltd. (Xi’an); BMS202 (HY-19745), Article Title: Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA Article Snippet: Zn (NO3)2•6H2O and 2-MeIM were purchased from Aladdin Holdings Group Co., Ltd (Shanghai); PEG-FA 2000, ICG, and FITC from Rixi Biotechnology Co., Ltd. (Xi’an); BMS202 (HY-19745), CCK-8 Assay:Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer Article Snippet: The percentage of PI-positive cells was quantified.The percentage of PI-positive cells was quantified.. To validate cell death inhibitors, RCC10 (1 × 10 5 cells/well) cells were seeded onto the 12-well plate for 12 h and pre-treated for 30 min with vehicle, Necrostatin-1 (10 μM), Ferrostatin-1 (2 μM), 3-MA (1.25 mM), or AC-FLTD-CMK (10 μM), followed by 3 days of co-treatment with vehicle or respective cell death activator, including Compound6i (0.5 μM, necroptosis activator, HY-144828, MCE), RSL3 (50 nM, ferroptosis activator, HY-100218A, MCE), Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer. Article Snippet: ssue Kit Qiagen Cat# 69504 RNeasy mini kit Qiagen Cat# 74104 KAPA mRNA HyperPrep Kit Roche Cat# 08098123702 Bioactive Compound Library Selleckchem Cat# L1700 Chemicals and recombinant proteins SGI1027 Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer. Article Snippet: The percentage of PI-positive cells was quantified.The percentage of PI-positive cells was quantified.. To validate cell death inhibitors, RCC10 (1 × 10 5 cells/well) cells were seeded onto the 12-well plate for 12 h and pre-treated for 30 min with vehicle, Necrostatin-1 (10 μM), Ferrostatin-1 (2 μM), 3-MA (1.25 mM), or AC-FLTD-CMK (10 μM), followed by 3 days of cotreatment with vehicle or respective cell death activator, including Compound6i (0.5 μM, necroptosis activator, HY-144828, MCE), RSL3 (50 nM, ferroptosis activator, HY-100218A, MCE), Article Title: Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA. Article Snippet: Zn (NO3)2•6H2O and 2-MeIM were purchased from Aladdin Holdings Group Co., Ltd (Shanghai); PEGFA 2000, ICG, and FITC from Rixi Biotechnology Co., Ltd. (Xi’an); BMS202 (HY-19745), Article Title: Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA Article Snippet: Zn (NO3)2•6H2O and 2-MeIM were purchased from Aladdin Holdings Group Co., Ltd (Shanghai); PEG-FA 2000, ICG, and FITC from Rixi Biotechnology Co., Ltd. (Xi’an); BMS202 (HY-19745), Double Staining:Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer Article Snippet: The percentage of PI-positive cells was quantified.The percentage of PI-positive cells was quantified.. To validate cell death inhibitors, RCC10 (1 × 10 5 cells/well) cells were seeded onto the 12-well plate for 12 h and pre-treated for 30 min with vehicle, Necrostatin-1 (10 μM), Ferrostatin-1 (2 μM), 3-MA (1.25 mM), or AC-FLTD-CMK (10 μM), followed by 3 days of co-treatment with vehicle or respective cell death activator, including Compound6i (0.5 μM, necroptosis activator, HY-144828, MCE), RSL3 (50 nM, ferroptosis activator, HY-100218A, MCE), Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer. Article Snippet: ssue Kit Qiagen Cat# 69504 RNeasy mini kit Qiagen Cat# 74104 KAPA mRNA HyperPrep Kit Roche Cat# 08098123702 Bioactive Compound Library Selleckchem Cat# L1700 Chemicals and recombinant proteins SGI1027 Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer. Article Snippet: The percentage of PI-positive cells was quantified.The percentage of PI-positive cells was quantified.. To validate cell death inhibitors, RCC10 (1 × 10 5 cells/well) cells were seeded onto the 12-well plate for 12 h and pre-treated for 30 min with vehicle, Necrostatin-1 (10 μM), Ferrostatin-1 (2 μM), 3-MA (1.25 mM), or AC-FLTD-CMK (10 μM), followed by 3 days of cotreatment with vehicle or respective cell death activator, including Compound6i (0.5 μM, necroptosis activator, HY-144828, MCE), RSL3 (50 nM, ferroptosis activator, HY-100218A, MCE), Article Title: Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA. Article Snippet: Zn (NO3)2•6H2O and 2-MeIM were purchased from Aladdin Holdings Group Co., Ltd (Shanghai); PEGFA 2000, ICG, and FITC from Rixi Biotechnology Co., Ltd. (Xi’an); BMS202 (HY-19745), Article Title: Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA Article Snippet: Zn (NO3)2•6H2O and 2-MeIM were purchased from Aladdin Holdings Group Co., Ltd (Shanghai); PEG-FA 2000, ICG, and FITC from Rixi Biotechnology Co., Ltd. (Xi’an); BMS202 (HY-19745), Flow Cytometry:Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer Article Snippet: The percentage of PI-positive cells was quantified.The percentage of PI-positive cells was quantified.. To validate cell death inhibitors, RCC10 (1 × 10 5 cells/well) cells were seeded onto the 12-well plate for 12 h and pre-treated for 30 min with vehicle, Necrostatin-1 (10 μM), Ferrostatin-1 (2 μM), 3-MA (1.25 mM), or AC-FLTD-CMK (10 μM), followed by 3 days of co-treatment with vehicle or respective cell death activator, including Compound6i (0.5 μM, necroptosis activator, HY-144828, MCE), RSL3 (50 nM, ferroptosis activator, HY-100218A, MCE), Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer. Article Snippet: ssue Kit Qiagen Cat# 69504 RNeasy mini kit Qiagen Cat# 74104 KAPA mRNA HyperPrep Kit Roche Cat# 08098123702 Bioactive Compound Library Selleckchem Cat# L1700 Chemicals and recombinant proteins SGI1027 Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer. Article Snippet: The percentage of PI-positive cells was quantified.The percentage of PI-positive cells was quantified.. To validate cell death inhibitors, RCC10 (1 × 10 5 cells/well) cells were seeded onto the 12-well plate for 12 h and pre-treated for 30 min with vehicle, Necrostatin-1 (10 μM), Ferrostatin-1 (2 μM), 3-MA (1.25 mM), or AC-FLTD-CMK (10 μM), followed by 3 days of cotreatment with vehicle or respective cell death activator, including Compound6i (0.5 μM, necroptosis activator, HY-144828, MCE), RSL3 (50 nM, ferroptosis activator, HY-100218A, MCE), Article Title: Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA. Article Snippet: Zn (NO3)2•6H2O and 2-MeIM were purchased from Aladdin Holdings Group Co., Ltd (Shanghai); PEGFA 2000, ICG, and FITC from Rixi Biotechnology Co., Ltd. (Xi’an); BMS202 (HY-19745), Article Title: Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA Article Snippet: Zn (NO3)2•6H2O and 2-MeIM were purchased from Aladdin Holdings Group Co., Ltd (Shanghai); PEG-FA 2000, ICG, and FITC from Rixi Biotechnology Co., Ltd. (Xi’an); BMS202 (HY-19745), Concentration Assay:Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer Article Snippet: The percentage of PI-positive cells was quantified.The percentage of PI-positive cells was quantified.. To validate cell death inhibitors, RCC10 (1 × 10 5 cells/well) cells were seeded onto the 12-well plate for 12 h and pre-treated for 30 min with vehicle, Necrostatin-1 (10 μM), Ferrostatin-1 (2 μM), 3-MA (1.25 mM), or AC-FLTD-CMK (10 μM), followed by 3 days of co-treatment with vehicle or respective cell death activator, including Compound6i (0.5 μM, necroptosis activator, HY-144828, MCE), RSL3 (50 nM, ferroptosis activator, HY-100218A, MCE), Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer. Article Snippet: ssue Kit Qiagen Cat# 69504 RNeasy mini kit Qiagen Cat# 74104 KAPA mRNA HyperPrep Kit Roche Cat# 08098123702 Bioactive Compound Library Selleckchem Cat# L1700 Chemicals and recombinant proteins SGI1027 Article Title: HIF-activated priming of TRAIL-induced cell death determines epigenetic vulnerability in kidney cancer. Article Snippet: The percentage of PI-positive cells was quantified.The percentage of PI-positive cells was quantified.. To validate cell death inhibitors, RCC10 (1 × 10 5 cells/well) cells were seeded onto the 12-well plate for 12 h and pre-treated for 30 min with vehicle, Necrostatin-1 (10 μM), Ferrostatin-1 (2 μM), 3-MA (1.25 mM), or AC-FLTD-CMK (10 μM), followed by 3 days of cotreatment with vehicle or respective cell death activator, including Compound6i (0.5 μM, necroptosis activator, HY-144828, MCE), RSL3 (50 nM, ferroptosis activator, HY-100218A, MCE), Article Title: Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA. Article Snippet: Zn (NO3)2•6H2O and 2-MeIM were purchased from Aladdin Holdings Group Co., Ltd (Shanghai); PEGFA 2000, ICG, and FITC from Rixi Biotechnology Co., Ltd. (Xi’an); BMS202 (HY-19745), Article Title: Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA Article Snippet: Zn (NO3)2•6H2O and 2-MeIM were purchased from Aladdin Holdings Group Co., Ltd (Shanghai); PEG-FA 2000, ICG, and FITC from Rixi Biotechnology Co., Ltd. (Xi’an); BMS202 (HY-19745), |

